Report cover image

Global Aesthetic Injectable Market Growth, Size, Trends Analysis - By Type, By Application, By End-User Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published Mar 11, 2025
Length 256 Pages
SKU # SPER20019398

Description

Aesthetic Injectable Market Introduction and Overview

According to SPER market research, ‘Aesthetic Injectable Market Size- By Type, By Application, By End-User – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Aesthetic Injectable Market is predicted to reach 39.72 billion by 2034 with a CAGR of 12.39%.

Aesthetic injectables have revolutionized cosmetic dermatology and plastic surgery by offering minimally invasive methods of facial rejuvenation and contouring. Botulinum toxin (Botox, Dysport, and Xeomin) and dermal fillers are the most often used injectables. They are often used to eliminate wrinkles, restore lost volume, increase facial symmetry, and improve skin texture without the need for surgery. With rising consumer awareness and technological advancements, the cosmetic injectable market has expanded dramatically in recent years.

Restraints: The global aesthetic injectable market has several obstacles that hinder its growth and usage. The strict regulatory system that oversees the authorization and distribution of injectables is a significant barrier. Stringent safety and efficacy criteria are enforced by regulatory authorities such as the United States Food and Drug Administration and the European Medicines Agency, which can lead to product delays and higher manufacturing costs.

Scope of the Report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034

Segments covered

By Type, By Application, By End-User.

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.

Companies Covered

Ipsen Pharma, AbbVie Inc., Merz GmbH and Co. KGaA, Galderma, Prollenium Medical Technologies Inc., Suneva Medical Inc., Sinclair Pharma, Medytox Inc., Revance Therapeutics Inc.

Aesthetic Injectable Market Segmentation:

By Type: Based on the Type, Global Aesthetic Injectable Market is segmented as; Collagen, Hyaluronic Acid, Botulinum Toxin, Polylactic Acid, Polymethyl-Methacrylate Microspheres (PMMA), Calcium Hydroxylapatite, Fat Injections, Others.

By Application: Based on the Application, Global Aesthetic Injectable Market is segmented as; Facelift, Facial Line Correction, Acne Scar Treatment, Wrinkle Reduction, Lip Enhancement, Lipoatrophy Treatment, Others.

By End-User: Based on the End-User, Global Aesthetic Injectable Market is segmented as; Hospitals And Ambulatory Surgery Centres, Dermatology And Cosmetic Clinics, Others.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa

Table of Contents

256 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Aesthetic Injectable Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Aesthetic Injectable Market
7. Global Aesthetic Injectable Market, By Type 2021-2034 (USD Million)
7.1. Collagen
7.2. Hyaluronic Acid
7.3. Botulinum Toxin
7.4. Polylactic Acid
7.5. Polymethyl-methacrylate Microspheres (PMMA)
7.6. Calcium Hydroxylapatite
7.7. Fat Injections
7.8. Others
8. Global Aesthetic Injectable Market, By Application 2021-2034 (USD Million)
8.1. Facelift
8.2. Facial Line Correction
8.3. Acne Scar Treatment
8.4. Wrinkle Reduction
8.5. Lip Enhancement
8.6. Lipoatrophy Treatment
8.7. Others
9. Global Spinal Implants and Devices Market, By End-User 2021-2034 (USD Million)
9.1. Hospitals & Ambulatory Surgery Centers
9.2. Dermatology & Cosmetic Clinics
9.3. Others
10. Global Aesthetic Injectable Market 2021-2034 (USD Million)
10.1. Global Aesthetic Injectable Market Size and Market Share
11. Global Aesthetic Injectable Market, By Region, 2021-2034 (USD Million)
11.1. Asia-Pacific
11.1.1. Australia
11.1.2. China
11.1.3. India
11.1.4. Japan
11.1.5. South Korea
11.1.6. Rest of Asia-Pacific
11.2. Europe
11.2.1. France
11.2.2. Germany
11.2.3. Italy
11.2.4. Spain
11.2.5. United Kingdom
11.2.6. Rest of Europe
11.3. Middle East and Africa
11.3.1. Kingdom of Saudi Arabia
11.3.2. United Arab Emirates
11.3.3. Qatar
11.3.4. South Africa
11.3.5. Egypt
11.3.6. Morocco
11.3.7. Nigeria
11.3.8. Rest of Middle-East and Africa
11.4. North America
11.4.1. Canada
11.4.2. Mexico
11.4.3. United States
11.5. Latin America
11.5.1. Argentina
11.5.2. Brazil
11.5.3. Rest of Latin America
12. Company Profile
12.1. Ipsen Pharma
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. AbbVie Inc.
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Merz GmbH and Co. KGaA
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. Galderma
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. Prollenium Medical Technologies Inc.
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. Suneva Medical Inc.
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Sinclair Pharma
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Medytox Inc.
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. Revance Therapeutics Inc.
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us